{"id":386691,"date":"2017-10-18T00:00:00","date_gmt":"2017-10-18T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/m360ve0005-medtech-minimally-invasive-vertebral-compression-fracture-treatments-global-2018-market-analysis\/"},"modified":"2026-04-14T10:07:13","modified_gmt":"2026-04-14T10:07:13","slug":"m360ve0005-medtech-minimally-invasive-vertebral-compression-fracture-treatments-global-2018-market-analysis","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/m360ve0005-medtech-minimally-invasive-vertebral-compression-fracture-treatments-global-2018-market-analysis\/","title":{"rendered":"Minimally Invasive Vertebral Compression Fracture Treatments | Global | 2018 | Market Analysis"},"content":{"rendered":"<p>The global\u00a0<abbr title=\"Minimally Invasive Vertebral Compression Fracture\">MIVCF<\/abbr>\u00a0treatment device market will be driven mainly by the growing aging and obese population across the globe. Furthermore, new product launches and increasing adoption of advanced premium-priced technologies will help overcome obstacles such as unfavorable reimbursement environments. Therefore, the market will see\u00a0moderate\u00a0growth through 2026.\u00a0<\/p>\n<p>This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for\u00a0<abbr title=\"Minimally Invasive Vertebral Compression Fracture\">MIVCF<\/abbr>\u00a0treatment devices in the global region across a 10-year period.<\/p>\n<p>\u00a0<\/p>\n<p><strong>The global\u00a0<abbr title=\"Minimally Invasive Vertebral Compression Fracture\">MIVCF<\/abbr>\u00a0treatment market will grow\u00a0moderately\u00a0through 2026, with\u00a0<abbr title=\"Multinational Corporation\">MNC<\/abbr>s\u00a0dominating\u00a0the market and mergers and acquisitions remaining common.<\/strong><\/p>\n<p>Which companies are the largest competitors in each of the\u00a0<abbr title=\"Minimally Invasive Vertebral Compression Fracture\">MIVCF<\/abbr>\u00a0treatment markets in the global region?<\/p>\n<p>What factors contribute to the success of these competitors in the global\u00a0<abbr title=\"Minimally Invasive Vertebral Compression Fracture\">MIVCF<\/abbr>\u00a0treatment market?<\/p>\n<p>What can local and international competitors do to succeed in this market?<\/p>\n<p>What recent mergers and acquisitions have taken place, and how do they affect market shares?<\/p>\n<p><b>The continuing introduction of products and expanded indications in the\u00a0<abbr title=\"Minimally Invasive Vertebral Compression Fracture\">MIVCF<\/abbr>\u00a0treatment\u00a0market will drive market growth.<\/b><\/p>\n<p>How will the introduction of new products enable manufacturers to mitigate negative pricing trends and maintain profit margins?<\/p>\n<p>How quickly will the\u00a0<abbr title=\"Minimally Invasive Vertebral Compression Fracture\">MIVCF<\/abbr>\u00a0market expand in the global region following the anticipated approval of new indications?<\/p>\n<p><strong>The unfavorable reimbursement environments and\u00a0<\/strong><strong>strong cost constraints\u00a0<\/strong><strong>experienced by health care facilities globally, particularly in Europe, will hinder the adoption of premium-priced\u00a0<abbr title=\"Minimally Invasive Vertebral Compression Fracture\">MIVCF<\/abbr>\u00a0treatment devices.<\/strong><\/p>\n<p>Which devices will be most impacted by this trend?<\/p>\n<p>What strategies will companies use to remain competitive despite these challenges?<\/p>\n<p><strong>Changing\u00a0<abbr title=\"Minimally Invasive Vertebral Compression Fracture\">MIVCF<\/abbr>\u00a0treatment\u00a0reimbursement landscapes in the Asia Pacific region have strongly impacted market dynamics.<\/strong><\/p>\n<p>How have changes to reimbursement in Australia, Japan, and South Korea affected the growth of\u00a0<abbr title=\"Minimally Invasive Vertebral Compression Fracture\">MIVCF<\/abbr>\u00a0treatments performed in those regions?<\/p>\n<p>Which of the countries\u00a0represents the greatest opportunity for growth in the Asia Pacific region?<\/p>\n<p>What strategies are competitors using to expand product penetration and market share when reimbursement is lacking?<\/p>\n","protected":false},"template":"","class_list":["post-386691","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-minimally-invasive-vertebral-compression-fracture-treatments","medtech-therapy-area-orthopedics","medtech-date-889"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/386691","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/386691\/revisions"}],"predecessor-version":[{"id":388190,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/386691\/revisions\/388190"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=386691"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}